Generic Timolol Maleate Ophthalmic Gel-Forming Solution from Canada
Gel-forming ophthalmic solution with timolol maleate for once-daily glaucoma treatment, in retail multi-dose bottles. It qualifies for HTS 3004.90.92.72 as an eye-affecting medicament in measured doses containing timolol maleate, distinct from standard drops. The gel matrix provides prolonged release for therapeutic efficacy.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Except as provided in heading 9903.04.61, patented pharmaceutical articles as provided for in subdivisions (c) and (d) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Ensure gel formulation stability testing reports are available for CBP review during ophthalmic import clearance
• Comply with USP standards for sterility and include batch certificates to expedite FDA admission
• Watch for misclassification pitfalls by specifying 'measured dose retail packing' in entry documentation